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Background: Interstitial lung diseases (ILDs) often present diagnostic challenges to
both the clinician and pathologist. Surgical lung biopsy (SLB) is often pursued in the
evaluation of ILD and the clinician uses the histopathologic conclusions to guide
management. However, the agreement between general and pulmonary pathologists
in histopathologic diagnosis of ILD has not been established.
Objective: To determine the agreement between general and pulmonary pathol-
ogists in the histopathologic interpretation of ILDs and whether disagreements result
in changes in clinical management.
Methods: We retrospectively reviewed all patients who underwent SLB for ILD at
our institution, between 1996 and 2002. We compared the interpretations of general
pathologists to those of pulmonary pathologists to evaluate the degree of inter-rater
agreement. We assumed the specialist pathologist represented the
’ ’
gold standard.’’
We further determined if changes in the histopathologic diagnosis altered clinical
management.
Results: Of 83 subjects who underwent SLB, 44 (mean age 58.5714.2, 47.7% male)
were examined by both general and specialty pathologists. There was poor
agreement between the two sets of reviewers. The histopathologic interpretation
by the specialist pathologist differed from the generalist in 52.3% of cases (kappa
0.21, Po0:0001). This high rate of discordance led to frequent (60.0%) changes inElsevier Ltd. All rights reserved.
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C.J. Lettieri et al.1426clinical management. As a screening test for usual interstitial pneumonia, the
observations of the general pathologist had moderate sensitivity and specificity
(76.5% and 66.7%, respectively).
Conclusions: General and pulmonary pathologists often differ in their interpretation
of the histopathology in ILD. This significant discordance may have important clinical
implications for patient care.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Interstitial lung diseases (ILDs) comprise numerous
processes which affect the lung parenchyma.1 The
various forms, potential causative agents, and
clinical presentations often present diagnostic and
therapeutic challenges. Clinical and radiographic
findings are typically non-specific, creating diffi-
culties in distinguishing one form from another.
Moreover, in order to properly counsel patients
regarding prognosis and to make appropriate
management decisions it is important to strive for
diagnostic certainty.
Surgical lung biopsy (SLB) represents one tool for
determining the precise diagnosis in cases of
ILD. SLB offers the greatest diagnostic sensitivity
for ILDs, with yields greater than 90%.2,3 In
most instances, SLB has been shown to be superior
to clinical and radiographic assessment of ILDs.2,3
Although the American Thoracic Society state-
ment on idiopathic pulmonary fibrosis (IPF)
concludes that a reliable clinical diagnosis of this
disease can be made in patients with typical
findings on high-resolution computed tomography,
subsequent studies have shown that a clinical
diagnosis of IPF lacks sensitivity.4,5 This is especially
true in individuals who present with atypical
features.5
SLB exposes the patient to the risks associated
with this procedure.6 Physicians and patients
accept these risks to confirm the diagnosis,
to formulate treatment plans, and to obtain
prognostic information. However, the validity of
histopathologic diagnosis is yet to be confirmed and
clinicians regularly assume that the diagnosis
rendered in the pathology report is correct.
Just as ILDs pose considerable diagnostic complex-
ity to the clinician, they may provide similar
problems for the general pathologist. Because
of this, investigators have devised several scoring
systems to aid in the pathologic evaluation of
lung tissue in the assessment of ILDs. However,
few of these tools have been shown to reliably
guide clinicians or to improve diagnostic accuracy.
For example, Hyde et al.7 demonstrated the utility
of a semiquantative pathologic scoring system
in the evaluation of IPF. Cherniak and co-workersestablished a more simplified scoring system for IPF
that could be readily used by the general pathol-
ogist.8 While both systems showed reliability in the
assessment of fibrotic changes consistent with IPF,
neither study specifically focused on the evaluation
of other forms of ILDs.
We hypothesized that general pathologists’ lack
of familiarity with ILDs coupled with the complexity
of these diseases might result in unreliable diag-
nostic conclusions. We also hypothesized that
clinicians would alter their management strategies
after a review of specimens by specialist patholo-
gists. To explore our hypotheses, we conducted a
retrospective review of our experience with SLB for
suspected ILD.Methods
Study population
We reviewed the records and radiographs of all
patients who underwent SLB for suspected ILD
at our institution between January 1996 and
December 2002. The institution (Walter Reed
Army Medical Center, Washington, DC) is a large,
multidisciplinary, tertiary care referral center.
All subjects initially presented to the pulmonary
clinic with both clinical and radiographic
evidence of ILD. SLB was obtained to determine
the specific diagnosis. The decision to refer
the patient for SLB was left to the primary
pulmonary physician and was not standardized.
A general pathologist initially reviewed all SLB
specimens. In some instances, specimens were
further reviewed by pathologists with expertise
in ILD from the Armed Forces Institute of Pathology
(AFIP). Only those patients whose samples
were examined by a pathologist specializing
in pulmonary diseases were included in the final
cohort. For all patients, irrespective of whether
their specimens were sent for further review by
pulmonary pathologists, we abstracted information
regarding subject demographics, pulmonary func-
tion, use of tobacco, and need for supplemental
oxygen.
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Tissue samples were obtained by SLB. Each patient
had multiple sites sampled by either open lung
biopsy or video assisted thorocotomy (VATS) lung
biopsy. The samples were taken from one lung,
typically chosen by burden of disease or ease of
surgery. The institution’s general pathology depart-
ment initially evaluated each sample of lung tissue.
Appropriate studies and special staining were
conducted in order to yield a histopathologic
diagnosis. Following the initial evaluation,
the same samples were sent to the AFIP for further
evaluation. The AFIP is a large pathology
referral center with multiple subspecialists in
various disciplines of pathology. AFIP pathologists
specializing in pulmonary diseases reexamined
each sample. When necessary, further studies and
staining were conducted in order to yield a
diagnosis. The final diagnosis rendered by the AFIP
represented the consensus of several pulmonary
pathologists.End points
We defined our primary outcome as the correlation
between the diagnosis rendered by a general
pathologist and that made by a pulmonary pathol-
ogy specialist. The frequency of changes in clinical
management following alterations in the initial
pathologic diagnosis served as a secondary end
point. We defined clinical management as being
altered if antibiotics, corticosteroids, or other
immune modulators were started or discontinued
following the interpretation by expert pathologists.
If care was withdrawn as a result of the final
diagnosis this was further considered to represent a
change in management.Table 1 Clinical characteristics of patients as a function
Specimen reviewed
pathologists (n ¼ 44
Age, years, mean7SD 58.5714.2
% Male 47.7%
FVC, % predicted, mean7SD 70.2714.3%
FEV1, % predicted, mean7SD 68.6715.4%
DLCO, mean7SD 43.7713.5%
% Requiring supplemental oxygen
at time of biopsy
54.5%
Abbreviations: DLCO, diffusion of carbon monoxide; FEV1, forc
standard deviation.
There are no statistically significant differences between theStatistical analysis
We used the kappa statistic to determine the inter-
rater agreement between generalist and specialist
pathologists. The kappa statistic was also used to
explore the correlation between the conclusions of
the general pathologists and the initial clinical
diagnosis. We calculated the sensitivity and speci-
ficity of the conclusions of the general pathologists
for the diagnosis of usual interstitial pneumonia
(UIP) and employed the findings of the specialist
pathologists as the
’ ’
gold standard’’.
In order to assess the potential for selection bias
in our final study cohort we compared the patients
whose specimens were reviewed by pulmonary
pathologists to those whose biopsies were not
referred to AFIP. Specifically, we attempted to
identify any differences in the cohorts as it related
to demographics, use of supplemental oxygen, and
pulmonary function. For this analysis, continuous
variables were compared with the Student’s t-test
while categorical variables were analyzed using the
Fisher’s exact test. All tests were two sided and a P
value of o0.05 was assumed to represent statis-
tical significance.Results
During the study period, 83 patients underwent
SLB. Of these, samples from 44 patients (52.3%)
were further reviewed by pathologists specializing
in pulmonary diseases. These patients comprised
the final cohort. The mean age of the cohort was
58.5714.2 years and 47.7% were male. The
demographics and clinical characteristics of the
final cohort are shown in Table 1. Patients who had
their biopsies reviewed by the expert pathologistsof specialty pathology review.
by specialty
)
No review by specialty pathologist
(n ¼ 39)
57.4714.3
66.7%
69.3716.3%
67.0716.6%
41.6716.3%
43.6%
ed expiratory volume in 1 s; FVC, forced vital capacity, SD,
two cohorts.
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Table 2 Frequency of histopathologic diagnoses.
Condition Specialty
pathologists
General
pathologists
Usual interstitial
pneumonia
17 22
Non-specific
interstitial
pneumonia
10 7
Sarcoidosis 4 0
Cryptogenic
organizing
pneumonia
3 3
Diffuse alveolar
damage
2 1
Infection 2 1
Malignancy 2 0
Other 5 10
C.J. Lettieri et al.1428did not appear to be clinically different from those
whose specimens were not over read.
A final histopathologic diagnosis was rendered in
93.2% of patients by the institution’s general
pathologist and in all cases by the AFIP. Multiple
ILDs were diagnosed. As shown in Table 2 the three
most common diagnoses rendered by general
pathologists were UIP, non-specific interstitial
pneumonia (NSIP), and cryptogenic organizing
pneumonia (COP). Specialty pathologists most
commonly found UIP, NSIP, and sarcoidosis.
There was little agreement between the clinical
diagnoses pre-operatively and the diagnoses re-
ported by the general pathologists. In approxi-
mately half the cases, the initial pathologic
diagnosis differed from the clinician’s conclusions.
However, there was also poor agreement between
the general and specialty pathologists. Specifically,
the initial histopathologic diagnosis differed from
the final AFIP diagnosis in 52.3% of subjects
(kappa ¼ 0.21, Po0:0001). This high degree of
discordance resulted in alterations in the manage-
ment of nearly 60% patients for whom the diagnosis
was changed. Among these 13 subjects, corticos-
teroids were discontinued in five instances but
were added to the treatment regimen in six
patients. Two individuals received new immuno-
suppressive agents after review of their biopsy
specimens by expert pathologists.
There was less inter-observer variability between
the clinicians and the specialty pathologists
(kappa ¼ 0.46, Po0:0001). In several cases, gen-
eral pathologists misclassified diseases that share
few common features. For example, general
pathologists labeled two patients finally diagnosedwith sarcoidosis as UIP. Similarly, one case of
Wegner’s granulomatous was diagnosed as COP
while one patient with the final diagnosis of COP
was felt to have UIP by the non-pulmonary
pathologists.
The correlation between general pathologists
and those specializing in pulmonary disorders was
greater in the subset of patients eventually
diagnosed with UIP as compared to other ILDs. In
cases with UIP as the final diagnosis, the general
pathologist agreed with the pulmonary pathologist
in 70.5% of subjects. Using the specialty patholo-
gists as the gold standard for the diagnosis of UIP
revealed that the interpretation of the general
pathologists had a sensitivity of 76.5% and a
specificity of 66.7%. The positive and negative
predictive value of the general pathologists at
identifying UIP were 59.1% and 81.8%, respectively.
In other, non-UIP ILDs, there was greater discor-
dance. For example, non-specialty pathologists
misclassified 8 of 10 subjects with NSIP.Discussion
ILDs comprise a multitude of disease processes with
overlapping and often non-specific clinical and
radiographic findings. As such, they can pose
significant diagnostic challenges even for experi-
enced clinicians who may obtain SLB to confirm the
diagnosis. However, the histopathologic interpreta-
tion of the specimen may not be reliable when
performed by a general pathologist who is unfami-
liar with these disorders. Reliance on the conclu-
sions of general pathologists may result in
misdiagnoses in the majority of patients.
The poor correlation between general and
pulmonary pathologists likely arises from the
inexperience and unfamiliarity of general patholo-
gists with uncommon disease processes. As in most
aspects of medicine, specialization provides a
higher degree of expertise. General pathologists,
though well trained, may have limited exposure to
ILD. Because of the rarity of ILD relative to other
conditions, general pathologists may review at
most several cases of ILD during their residencies
and, while in clinical practice, may only see a few
cases each year. Moreover, the general pathologist
often interprets the pathology specimen in a
vacuum and without the benefit of information
from the clinical exam and radiology studies. For
our study, on the other hand, the diagnosis
rendered by the pulmonary pathologists attempted
to incorporate clinical and radiographic findings to
help guide the histologic interpretation. In short, a
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clinical variables may improve diagnostic accuracy.
Our observation that pulmonologists’ clinical diag-
noses frequently differed from the final conclusions
reached by both general and pulmonary specialty
pathologists underscores the need for a multi-
disciplinary approach to the diagnosis of ILDs.
Supporting this hypothesis, Flaherty and colleges
demonstrated that the integration of clinical and
radiographic information along with histopathology
decreases interobserver variability and leads to
more congruent patient diagnoses in the approach
to ILD.11 Furthermore, it is important to note
that ILD poses difficulties not only for the general
pathologist but also for the pulmonologists.
For example, some patients with IPF have a
significant delay in their diagnoses because the
pulmonologist is not sure how best to address
suspected ILD.4 Finally, there may even be dis-
agreement among specialty pathologists in cases of
ILD. For UIP, Thomeer and co-workers demon-
strated that there was only fair correlation among
a group of pathologists with expertise in ILD when
evaluating SLB specimens from patients enrolled in
a clinical trial for IPF.12 Irrespective of the reasons
for the discordance between general and specialty
pathologists, clinicians must acknowledge this
potential confounder when reviewing pathology
reports.
Although many studies have focused on ap-
proaches to the diagnosis of ILD, none have
explored the accuracy of interpretations made by
general pathologists. For diseases other than
ILD, however, earlier investigators have reported
poor correlation between specialty and general
pathologists. Parker and colleges, for example,
showed the reliability for cervical histology im-
proved following consensus by multiple patholo-
gists.9 With respect to pulmonary pathology,
Newman et al. compared two pathologists’ inter-
pretations of 33 autopsies on patients with pul-
monary processes.10 They noted overall good
agreement especially in specimens with fibrosis or
acute inflammation.10
We noted that general pathologists seemed to do
better in instances of suspected UIP. Here their
accuracy was approximately 30% higher than for
non-UIP conditions. Although this may reflect
greater precision, it may also have resulted
because of the relative composition of the cohort
we studied. In our population, UIP was the most
frequently seen process. Hence the
’ ’
pre-test’’
probability for UIP was relatively high. Therefore,
the marginal increase in accuracy may have
occurred simply because UIP was a prevalent
condition. Put another way, given the prevalenceof UIP, the general pathologists marginal addition to
the pretest probability was only 11.4%.
What are the implications of our observations?
First, we suggest that clinicians consider having SLB
specimens reviewed by specialty pathologists.
Relying solely on general pathologists exposes the
patient to the risk of misdiagnoses. Since SLB
carries risk itself physicians ought strive to max-
imize the value of the procedure. More impor-
tantly, accurate clinical data can result in
alterations to patient care. However, certain
general pathologists clearly have sufficient skill at
interpreting SLB specimens. Therefore, institutions
should look to perform quality assurance assess-
ments of SLBs. To accomplish this, general pathol-
ogists could have their interpretations reviewed
periodically to assure there is high agreement with
the specialty pathologist. If this were the case,
there would be no need for routine re-evaluation of
the histopathology. Second, one must look cau-
tiously at earlier reports of the natural history of
certain ILDs such as NSIP and UIP. Few investigators
precisely state if the patients included in their
analyses had their tissue biopsies read by pathol-
ogists specializing in lung disease. In other words,
there is the potential for misclassification bias to
affect the conclusions made in prior studies of ILD.
Third, clinical trials of therapy for specific ILDs
should include panels of expert pathologists to
review biopsy specimens in order to determine if
the patients are in fact appropriate subjects for
enrollment or to at least identify a subset of
patients within the trial with a definitive diagnosis.
Allowing the inclusion of subjects who may actually
have conditions other than the one specifically
being studied increases the likelihood for con-
founding and complicates efforts to find effective
treatments for these frustrating diseases. Finally,
integrating clinical and radiographic findings may
improve the precision of the pathologists’ inter-
pretation.
Our study has several limitations. First, it was a
retrospective analysis and therefore is exposed to
several forms of bias. We attempted to control for
these factors by comparing patients who did not
have their biopsies reviewed by expert pathologists
to those who did. This revealed that the two groups
of patients did not differ clinically. However, this
does not exclude the potential for selection bias to
have affected our observations. Second, the initial
referral for SLB was left to the primary pulmonary
physician and not all patients suspected to have an
ILD were offered SLB. It is possible that only those
individuals with atypical presentations were sent
for biopsy. Nonetheless, this only underscores our
conclusions regarding the need for review by
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where the physician concludes that the clinical
data are unclear and that it is therefore necessary
to pursue SLB, he/she relies heavily on the
pathologist to clarify a complex situation. Hence,
especially in these more challenging cases the need
for expert review becomes imperative. Even if one
conservatively assumes that the general patholo-
gists correctly interpreted all of the specimens not
sent for review, this would still result in a high rate
of misinterpretation with discordance in nearly
one-third of cases. Third, our sample size was small
which necessarily limits the strength of our
recommendations. Fourth, our study represents
the experience at a single referral center. This
necessarily limits the generalizability of our ob-
servations. In addition, we were unable to compare
the level of training or experience with surgical
specimens between general and pulmonary pathol-
ogists. However, our conclusions are that greater
expertise, whether from additional training or
experience with ILDs, should provide a more
accurate diagnosis.
In summary, we conclude that there is poor
correlation between general and pulmonary pathol-
ogists in the interpretation of SLBs in cases if ILD.
The findings of general pathologists are inaccurate
when using the observations of the pulmonary
pathologist as the reference standard. Alterations
in diagnosis made after review by expert patholo-
gists often leads to changes in patient manage-
ment. Future educational efforts must be directed
at both general pathologists and pulmonologists in
order to increase their familiarity with the diag-
nostic criteria for various ILDs with the hope that
this will improve outcomes for patients.Acknowledgements
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